Dorzagliatin
- Generic Name
- Dorzagliatin
- Drug Type
- Small Molecule
- Chemical Formula
- C22H27ClN4O5
- CAS Number
- 1191995-00-2
- Unique Ingredient Identifier
- X59W6980E8
- Background
Dorzagliatin is under investigation in clinical trial NCT03173391 (Long-term Efficacy and Safety of HMS5552 in T2DM).
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HMS5552 in Patients With Type 2 Diabetes
- First Posted Date
- 2014-03-04
- Last Posted Date
- 2017-11-20
- Lead Sponsor
- Hua Medicine Limited
- Target Recruit Count
- 53
- Registration Number
- NCT02077452
A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of Oral HMS5552 in Healthy Volunteers
- First Posted Date
- 2013-09-30
- Last Posted Date
- 2017-11-20
- Lead Sponsor
- Hua Medicine Limited
- Target Recruit Count
- 60
- Registration Number
- NCT01952535
- Locations
- 🇨🇳
Hua Medicine Limited, Shanghai, Shanghai, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath